Company · CIK 0001042418 · SIC 2834 — Pharmaceutical Preparations · OTC

Inhibitor Therapeutics, Inc. · INTI

Insider activity reported against this company. All insider holders · On EDGAR ↗

Period1M 3M 6M 1Y 2Y All datashares as filed — not split-adjusted

Open-market buys & salesbuys $97.60B · 1sales $27k · 1net $97.60B

Reported at this company — common stock

Trade	Reported (ET)	Insider	Shares	Avg price	Total	Owned after	Δ stake	Flags
Jul 1, 2026 GForm 4 →	Aug 4, 9:03 pm EDT	Black Robe Capital LLC +110% Owner	3,200,000	—	—	19,901,057	—	late
May 4, 2026 AForm 4 →	Aug 4, 1:33 pm EDT	Ronald E Osman +1Director, 10% Owner	50,000	—	—	23,614,985	—	late
May 4, 2026 AForm 4 →	Aug 4, 12:19 pm EDT	Michelle YanezDirector	50,000	—	—	1,221,271	—	late
May 4, 2026 AForm 4 →	Aug 4, 12:15 pm EDT	Samuel P Sears Jr.Director	50,000	—	—	1,229,543	—	late
May 4, 2026 AForm 4 →	Aug 4, 11:55 am EDT	Francis E Odonnell Jr.Chief Executive Officer, Director, 10% Owner	50,000	—	—	150,000	—	late
May 4, 2026 AForm 4 →	Jun 24, 12:34 pm EDT	Michael Allen JermanDirector	50,000	—	—	180,411	—	late
Jan 15, 2019 JForm 4 →	Jan 24, 7:49 pm EST	Mayne Pharma Ventures Pty Ltd +210% Owner	362,121	—	—	198,653,051	—	plan? late
Dec 20, 2018 AForm 4 →	Dec 26, 5:15 pm EST	Robert Daniel MartinDirector	60,000	$0.08	$4,800	116,000	—	plan? late
Dec 20, 2018 AForm 4 →	Dec 26, 5:15 pm EST	E. Brendan MagrabDirector	65,000	$0.08	$5,200	65,000	—	plan? late
Aug 30, 2018 SForm 4 →	Aug 31, 4:30 pm EDT	Garrison J. HasaraCFO and Treasurer	100,000	$0.27	$27,000	3,959,044	−2.46%	plan?
Jul 15, 2018 JForm 4 →	Dec 19, 6:09 am EST	Mayne Pharma Ventures Pty Ltd +210% Owner	184,798	—	—	198,290,930	—	plan? late
Dec 19, 2017 PForm 4 →	Feb 12, 2018, 8:00 pm EST	Stefan CrossDirector	600,000	$162,660.00	$97,596,000,000	0	—	plan? late
Dec 19, 2017 PForm 4 →	Feb 12, 2018, 7:47 pm EST	Mayne Pharma Ventures Pty Ltd +210% Owner	600,000	$162,660.00	$97,596,000,000	198,106,132	+0.30%	plan? late
Jun 30, 2017 SForm 4 →	Jul 12, 4:05 pm EDT	HedgePath, LLC10% Owner	2,500,000	—	—	79,627,069	—	plan? late
Mar 8, 2017 FMForm 4 →	Mar 10, 4:19 pm EST	W. Mark WatsonDirector	1,256,400	$0.34	$121,176	553,600	—	plan?
Mar 8, 2017 FMForm 4 →	Mar 10, 4:17 pm EST	Garrison J. HasaraCFO and Treasurer	9,940,956	$0.34	$999,925	4,059,044	—	plan?
Mar 8, 2017 FMForm 4 →	Mar 10, 4:16 pm EST	Nicholas J VircaPresident and CEO	21,355,957	$0.34	$2,146,834	8,727,519	—	plan?
Mar 8, 2017 MForm 4 →	Mar 10, 4:15 pm EST	Stefan CrossDirector	600,000	—	—	600,000	—	plan?
Mar 8, 2017 FMForm 4 →	Mar 10, 4:15 pm EST	Richard Dana OnoDirector	1,047,000	$0.34	$100,980	453,000	—	plan?
Nov 15, 2016 XForm 4 →	Nov 15, 9:06 pm EST	Mayne Pharma Ventures Pty Ltd +210% Owner	9,610,902	—	—	197,506,132	—	plan?
Nov 4, 2016 XForm 4 →	Nov 7, 9:17 pm EST	Mayne Pharma Ventures Pty Ltd +210% Owner	38,833,000	—	—	187,895,230	—	plan?
Jun 15, 2016 SForm 4 →	Jun 20, 4:10 pm EDT	HedgePath, LLC10% Owner	2,560,000	—	—	82,127,069	—	plan? late
Jun 15, 2016 PForm 4/A →	Jun 20, 4:08 pm EDT	Francis E Odonnell Jr.Executive Chairman, Director	2,560,000	—	—	16,560,000	—	plan?
Jun 15, 2016 SForm 4 →	Jun 17, 5:49 pm EDT	Francis E Odonnell Jr.Executive Chairman, Director	2,560,000	—	—	11,440,000	—	plan? amended
Jun 6, 2016 JForm 4 →	Jun 8, 7:00 pm EDT	Francis E Odonnell Jr.Executive Chairman, Director	6,000,000	—	—	14,000,000	—	plan?
May 25, 2016 AForm 4 →	May 27, 12:53 pm EDT	Mayne Pharma Group Ltd +210% Owner	27,885,000	—	—	149,062,230	—	plan?
Sep 10, 2015 PForm 4 →	Sep 14, 4:30 pm EDT	Francis E Odonnell Jr.Executive Chairman, Director	20,000,000	—	—	20,000,000	—	plan?
May 15, 2015 AForm 4 →	May 19, 4:58 pm EDT	Mayne Pharma Group Ltd +210% Owner	33,333,333	—	—	121,177,230	—	plan?
Aug 14, 2014 CSForm 4 →	Sep 14, 2015, 4:31 pm EDT	HedgePath, LLC10% Owner	102,156,842	—	—	104,687,069	—	plan? late

Reported at this company — derivatives (options, RSUs, warrants)

Trade	Reported (ET)	Insider	Shares	Avg price	Total	Owned after	Δ stake	Flags
Feb 3, 2019 AForm 4 →	Feb 5, 7:57 pm EST	Richard Dana OnoDirector	657,895	—	—	657,895	—
Feb 3, 2019 AForm 4 →	Feb 5, 7:57 pm EST	Robert Daniel MartinDirector	657,895	—	—	657,895	—
Feb 3, 2019 AForm 4 →	Feb 5, 7:54 pm EST	W. Mark WatsonDirector	657,895	—	—	657,895	—
Feb 3, 2019 AForm 4 →	Feb 5, 7:52 pm EST	E. Brendan MagrabDirector	986,842	—	—	986,842	—
Jul 5, 2018 PForm 4 →	Jul 6, 5:11 pm EDT	Mayne Pharma Ventures Pty Ltd +210% Owner	5,797,103	—	—	1,739,131	—
Mar 13, 2018 AForm 4 →	Mar 15, 8:15 pm EDT	Robert Daniel MartinDirector	309,000	—	—	56,000	—
Mar 13, 2018 AForm 4 →	Mar 15, 6:39 pm EDT	E. Brendan MagrabChairman of the Board, Director	345,000	—	—	345,000	—
Mar 13, 2018 AForm 4 →	Mar 15, 5:07 pm EDT	Richard Dana OnoDirector	309,000	—	—	56,000	—
Mar 13, 2018 AForm 4 →	Mar 15, 5:01 pm EDT	W. Mark WatsonDirector	329,000	—	—	76,000	—
Mar 13, 2018 AForm 4 →	Mar 15, 5:00 pm EDT	Garrison J. HasaraCFO and Treasurer	260,000	—	—	260,000	—
Mar 13, 2018 AForm 4 →	Mar 15, 5:00 pm EDT	Nicholas J VircaPresident and CEO	310,000	—	—	310,000	—
Jan 10, 2018 PForm 4 →	Jan 11, 9:21 am EST	Mayne Pharma Ventures Pty Ltd +210% Owner	8,695,653	—	—	2,608,696	—
May 4, 2017 AForm 4 →	Jul 19, 7:43 pm EDT	Robert Daniel MartinDirector	60,000	—	—	60,000	—	late
May 4, 2017 AForm 4 →	Jul 19, 7:41 pm EDT	E. Brendan MagrabChairman of the Board, Director	65,000	—	—	65,000	—	late
Mar 8, 2017 MForm 4 →	Mar 10, 4:19 pm EST	W. Mark WatsonDirector	900,000	—	—	0	—
Mar 8, 2017 MForm 4 →	Mar 10, 4:17 pm EST	Garrison J. HasaraCFO and Treasurer	7,000,000	—	—	0	—
Mar 8, 2017 MForm 4 →	Mar 10, 4:16 pm EST	Nicholas J VircaPresident and CEO	15,041,738	—	—	0	—
Mar 8, 2017 MForm 4 →	Mar 10, 4:15 pm EST	Stefan CrossDirector	600,000	—	—	0	—
Mar 8, 2017 MForm 4 →	Mar 10, 4:15 pm EST	Richard Dana OnoDirector	750,000	—	—	0	—
Nov 15, 2016 XForm 4 →	Nov 15, 9:06 pm EST	Mayne Pharma Ventures Pty Ltd +210% Owner	9,610,902	—	—	23,504,236	—
Nov 4, 2016 XForm 4 →	Nov 7, 9:17 pm EST	Mayne Pharma Ventures Pty Ltd +210% Owner	38,833,000	—	—	333	—
Jul 1, 2016 AForm 4 →	Jul 6, 4:32 pm EDT	W. Mark WatsonDirector	400,000	—	—	200,000	—
Jul 1, 2016 AForm 4 →	Jul 6, 4:32 pm EDT	Samuel P Sears Jr.Director	300,000	—	—	150,000	—
Jul 1, 2016 AForm 4 →	Jul 6, 4:30 pm EDT	Richard Dana OnoDirector	300,000	—	—	150,000	—
May 25, 2016 AForm 4 →	May 27, 12:53 pm EDT	Mayne Pharma Group Ltd +210% Owner	28,364,236	—	—	71,948,138	—
Aug 14, 2015 AForm 4 →	Aug 18, 4:31 pm EDT	Stefan CrossDirector	300,000	—	—	300,000	—
Aug 14, 2015 AForm 4 →	Aug 18, 4:31 pm EDT	Richard Dana OnoDirector	300,000	—	—	300,000	—
Aug 14, 2015 AForm 4 →	Aug 18, 4:30 pm EDT	Samuel P Sears Jr.Director	300,000	—	—	300,000	—
Aug 14, 2015 AForm 4 →	Aug 18, 4:30 pm EDT	W. Mark WatsonDirector	400,000	—	—	400,000	—
May 15, 2015 AForm 4 →	May 19, 4:58 pm EDT	Mayne Pharma Group Ltd +210% Owner	33,333,333	—	—	43,583,902	—
Aug 6, 2014 AForm 5 →	Feb 6, 2015, 4:34 pm EST	Garrison J. HasaraCFO and Treasurer	7,000,000	—	—	3,500,000	—
Jul 18, 2014 AForm 5 →	Feb 6, 2015, 4:38 pm EST	W. Mark WatsonDirector	300,000	—	—	300,000	—
Jul 18, 2014 AForm 5 →	Feb 6, 2015, 4:37 pm EST	Richard Dana OnoDirector	300,000	—	—	300,000	—
Jul 18, 2014 AForm 5 →	Feb 6, 2015, 4:36 pm EST	Samuel P Sears Jr.Director	300,000	—	—	300,000	—
Jul 18, 2014 AForm 5 →	Feb 6, 2015, 4:33 pm EST	Nicholas J VircaPresident and CEO	15,041,738	—	—	15,041,738	—
Jul 18, 2014 AForm 5 →	Feb 6, 2015, 4:33 pm EST	Stefan CrossDirector	300,000	—	—	300,000	—